|
|
|
|
| Targeted protein degradation (TPD) is transforming drug discovery by opening new possibilities for previously undruggable targets. Join leading experts as they explore the evolution of PROTACs, molecular glues, and linker chemistries, along with discovery technologies, mechanism selection, translation from animals to humans, and safety considerations such as off-target effects and long-term protein knockdown. Register free to hear insights directly from field leaders. Click here to learn more. |
|
|
|
|
In a live audience poll, 46% of respondents cited validation and trust as the biggest barriers to broader organ‑on‑chip adoption. The result suggests the technology itself is no longer the main hurdle; instead, confidence in reproducibility, benchmarking, and fit‑for‑purpose use will determine how quickly these models are integrated into drug discovery decision‑making. |
|
|
|
|
|
| A Miniaturized, Semi-Automated RNA-seq Workflow | Application Note | By Samuel Rulli, Stuart Tugendreich, Kamila Koprowska, et al., QIAGEN | A streamlined RNA‑seq workflow enables high‑throughput gene expression profiling directly from cell lysates, reducing cost and complexity. See how this approach accelerates lead selection. |
|
|
| Standardization Of Analytical Data: Best Practices | White Paper | Revvity Signals Software, Inc. | Standardized analytical data is key to improving data quality, reuse, and AI readiness. Explore the challenges of fragmented formats and gain practical guidance on building future-proof foundations. |
|
|
| The Complete Guide To ELISA | E-Book | INTEGRA Biosciences | Gain insight into ELISA fundamentals, data interpretation, and workflow optimization, supported by real lab examples and step‑by‑step guidance to help researchers improve accuracy and reduce variability. |
|
|
|
|
|
|
